Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
326 participants
INTERVENTIONAL
2020-03-01
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Honey used for dressing will be 'Langnese Honey". Langnese honey is raw honey / unprocessed packed as collected, quality and quantity will be same for patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Pure Honey Dressing in Contrast to Alvogyl in the Resolution of Dry Socket
NCT06456060
Antibacterial Effect of New Herbal Paste Used as an Intracanal Medication
NCT05657132
The Efficacy of Hyaluronic Acid and Honey in Healing of Multiple Extraction Sockets of Primary Teeth Compared to Saline
NCT05161403
Propolis Versus Calcium Hydroxide on Post-Operative Pain in Patients With Necrotic Pulp
NCT04983524
Lesion Sterilization And Tissue Repair Versus Zinc Oxide And Eugenol For Treatment of Necrotic Primary Molars
NCT05448937
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
EUSOL is solution commonly used for dressing of wounds. Honey is also used for dressing of wounds. Honey is a viscous, supersaturated sugar derived from nectar gathered by a honeybee. Honey enhances wound healing by providing moist environment, antibacterial activity, deodorizes, decrease inflammation, edema and exudation. Honey increase rate of wound healing by promoting angiogenesis, granulation and epithelization. Dressing will be done by residents of our ward under supervision of faculty. At first time of debridement pus or tissue will be sent for culture and sensitivity meanwhile broad-spectrum antibiotic will be started. Once dressing will started, wide wound span will be measured and assessed daily for granulation tissue and removal of slough. Questionnaire will be filled by PI for allergic reaction to solution, appearance of granulation tissue and hospital stay.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Honey
Topical honey to be used for dressing 4ml per square inch.
Honey
Dressing of necrotizing fascitis wounds with honey.
EUSOL
Dressing of necrotizing fascitis wounds with EUSOL.
EUSOL
EUSOL soaked gauze to be placed over the wound as dressing.
Honey
Dressing of necrotizing fascitis wounds with honey.
EUSOL
Dressing of necrotizing fascitis wounds with EUSOL.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Honey
Dressing of necrotizing fascitis wounds with honey.
EUSOL
Dressing of necrotizing fascitis wounds with EUSOL.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Necrotizing fasciitis wounds
* Wide span of wound \<20cm
Exclusion Criteria
* Traumatic wounds
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dow University of Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lajpat Rai
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr Ruth K.M Pfau Civil Hospital
Karachi, Sindh, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-1491/DUHS/Approval/2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.